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Objective: Imprinted genes are crucial for the growth and development of fetal and juvenile mammals. Altered imprinted gene dosage causes a
variety of human disorders, with growth and development during these crucial early stages strongly linked with future metabolic health in
adulthood. Neuronatin (Nnat) is a paternally expressed imprinted gene found in neuroendocrine systems and white adipose tissue and is regulated
by the diet and leptin. Neuronatin expression is downregulated in obese children and has been associated with stochastic obesity in C57BL/6
mice. However, our recent studies of Nnat null mice on this genetic background failed to display any body weight or feeding phenotypes but
revealed a defect in glucose-stimulated insulin secretion due to the ability of neuronatin to potentiate signal peptidase cleavage of preproinsulin.
Nnat deﬁciency in beta cells therefore caused a lack of appropriate storage and secretion of mature insulin.
Methods: To further explore the potential role of Nnat in the regulation of body weight and adiposity, we studied classical imprinting-related
phenotypes such as placental, fetal, and postnatal growth trajectory patterns that may impact upon subsequent adult metabolic phenotypes.
Results: Here we ﬁnd that, in contrast to the lack of any body weight or feeding phenotypes on the C57BL/6J background, deletion of Nnat in
mice on 129S2/Sv background causes a postnatal growth restriction with reduced adipose tissue accumulation, followed by catch up growth after
weaning. This was in the absence of any effect on fetal growth or placental development. In adult 129S2/Sv mice, Nnat deletion was associated
with hyperphagia, reduced energy expenditure, and partial leptin resistance. Lack of neuronatin also potentiated obesity caused by either aging or
high fat diet feeding.
Conclusions: The imprinted gene Nnat plays a key role in postnatal growth, adult energy homeostasis, and the pathogenesis of obesity via catch
up growth effects, but this role is dependent upon genetic background.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Genomic imprinting results in monoallelic expression of a subset of
mammalian genes speciﬁed by their parent-of-origin [1]. Many of
these w150 genes are critical not only for placental function and
normal fetal growth and development [2e5] but also in a wide range
of processes vital for the survival and development of neonates
including thermoregulation, feeding behavior, and regulation of
glucose and lipid metabolism [6e14]. The most widely accepted
theory for the existence of genomic imprinting is the ‘parental con-
ﬂict’ hypothesis, which predicts that females, who are equally related
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www.molecularmetabolism.comresources over multiple litters and pups. In contrast, with possible
multiple paternity across litters, males are related to just some of the
offspring of a speciﬁc mother; therefore, it is in his genetic interest for
his offspring to extract maximal maternal resources [15]. The
parental conﬂict hypothesis is consistent with the observed silencing
of growth restriction genes by the paternal genome and silencing of
growth promoting genes by the maternal genome [16]. Highlighting
the importance of imprinted gene dosage, human genetic disorders
and mouse models with altered imprinted gene expression are
associated with a wide range of diseases ranging from psychiatric
conditions and cancer to metabolic disorders such as obesity and
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Original Articleimprinted genes in the postnatal period strongly inﬂuences adult
health status [26,27].
Neuronatin (Nnat) (also known as Peg5) is a paternally expressed
imprinted gene found in neuroendocrine systems including the hypo-
thalamus, pancreatic beta cells, and pituitary as well as in adipose
tissue [28e32]. Nnat expression peaks in the developing fetus and the
immediate postnatal period but is also maintained throughout adult-
hood in mice at these sites [29,33e35]. Unlike the majority of
imprinted genes, which are found in imprinting clusters, the Nnat gene
resides in a ‘microimprinted’ region within the intronic sequence of the
neighboring biallelic gene Blcap, with differential Nnat expression likely
controlled by localized methylation of the silenced maternal allele
[32,36e38]. Nnat expression is acutely regulated by nutrient status in
metabolic tissues, and by leptin in various hypothalamic nuclei that are
key to controlling feeding behavior and energy expenditure [28,39e
41]. Nnat expression has also been associated with a TRIM28-
dependent mechanism thought to contribute to the stochastic
obesity seen in mice on some genetic backgrounds [42]. Single
nucleotide polymorphisms in the human NNAT locus are associated
with extreme childhood obesity and reduced expression of NNAT is
found in human adipose tissue in obese children. Together, these data
suggested a role for neuronatin in the regulation of body weight and
adiposity potentially via effects upon feeding behavior [28,42,43].
We have recently reported that in pancreatic beta cells NNAT interacts
with the signal peptidase complex (SPC) on the endoplasmic reticulum
membrane, facilitating translocation of nascent preproinsulin prior to its
cleavage by the SPC. Mice with paternal-deletion of Nnat on both the
129S2/Sv and C57BL/6J genetic backgrounds display reduced beta cell
storage and secretion of mature insulin due to defects in early peptide
handling. Blunting of in vivo glucose-stimulated insulin secretion
resulted in perturbed glucose homeostasis under conditions of nutrient-
excess in these null mice on a C57BL/6J background [41]. However, on
this genetic background we did not detect signiﬁcant changes in body
weight and related phenotypes such as feeding in mice with global
deletion of Nnat either at the postnatal stage or in adulthood. In view of
this somewhat surprising result, we have now undertaken extensive
longitudinal analysis of the effects of Nnat deﬁciency in 129S2/Sv mice.
This genetic background, possibly due to strain differences in early
development, has historically been shown to reveal roles for both
imprinted and non-imprinted genes in terms of early growth, subtle
phenotypes that may be obscured on the obesity-prone C57BL/6J
background [44e48]. In our current studies, we found that deletion of
Nnat led to a transient postnatal growth restriction followed by catch up
growth after weaning, despite normal weight in utero on a 129S2/Sv
background. In adulthood, Nnat null mice displayed decreased energy
expenditure, blunted leptin sensitivity, and hyperphagia, resulting in
obesity under high fat diet-feeding or associated with aging. Together,
these studies indicate the importance for Nnat function, possibly due to
its modulation of signal peptide processing, during postnatal growth and
the effect that this early-life adversity has on key processes governing
feeding and energy homeostasis in adulthood.
2. METHODS AND MATERIALS
2.1. Animals and diets
ARRIVE guidelines were used for the designing and reporting of animal
experiments. When possible, investigators were blinded to genotype of
both live animals and tissue/blood samples. For experiments involving
feeding studies, mice were randomized by genotype for study groups,
and a crossover design was used. All metabolic studies were repli-
cated in at least two independent cohorts.2
 2018 The Authors. Published by Elsevier GGeneration and maintenance of mice with global deletion of Nnat have
been described previously [41]. This line was backcrossed in our
transgenic animal facility >8 generations onto the 129S2/Sv (Envigo)
background before intercrossing of mutant animals for generation of
experimental cohorts. Experimental cohorts of group housed, mutant
male (unless otherwise stated) mice, and their control littermates at
ages described in the text were maintained on a 12-hour light/dark cycle
with free access to water and standard mouse chow (RM3, Special Diet
Services) and housed in speciﬁc pathogen-free barrier facilities. All
animal work was carried out in accordance with the UK Animals (Sci-
entiﬁc Procedures) Act (1986) as well as being approved by the Imperial
College Animal Welfare and Ethical Review Body and by the UK Home
Ofﬁce. For high fat diet (D12451, 45% energy from fat, Research Diets)
feeding, animals were fed diet from 10 weeks of age. Embryonic and
placental wet weights were taken at the stated time points after the
formation of a discernible plug. Yolk sac DNA was used for genotyping.
2.2. Metabolic analysis
Measurement of body weights and tail vein blood collection were
performed as previously described [49]. Levels of serum leptin were
determined by ELISA (Millipore). Fat mass was quantiﬁed using an
EchoMRI Quantitative Whole Body Composition analyzer (Zinsser An-
alytic) on unanesthetized animals. Assessment of food intake and
leptin sensitivity was performed in singly housed mice for 3 consec-
utive experimental days as previously described [49] using 1.5 mg/kg
recombinant mouse leptin (R&D Systems).
Metabolic rate was measured by indirect calorimetry with the use of a
comprehensive lab animal monitoring system (CLAMS, Columbus In-
struments). Mice were singly housed, with energy expenditure (using
constants according to [50]) determined over a 96-hour period. Core
body temperature was assessed using a rectal thermometer (MM2000
digital thermometer, TME Thermometers).
For stimulation of growth hormone secretion (GH) in vivo, overnight
fasted mice were given a single intraperitoneal injection of insulin
(0.4 IU/kg) the following morning to induce hypoglycemia. Tail vein
blood was collected prior to, and 1 h after, the insulin injection. GH
levels in whole pituitary and in serum were assessed by ELISA
(Millipore).
2.3. Biochemical determination of placental glycogen concentration
Glycogen was extracted from whole placenta, resuspended in distilled
H2O, and glycogen concentration quantiﬁed as described in [46,51].
2.4. Histological techniques
Placentas and white adipose tissue (WAT) were ﬁxed overnight in
phosphate-buffered 4% paraformaldehyde (PFA), dehydrated in
ethanol, embedded in parafﬁn, and 10 mm sections were cut on a
microtome (Leica). Sections were stained with hematoxylin and eosin
(H&E) [46], and light microscope images were used to measure
adipocyte area with ImageJ. Four randomly selected ﬁelds of view
were used per section, with two sections taken at four different medial
points through the embedded tissue. Data were averaged per medial
point, and all counts were performed blindly.
2.5. Expression analysis
For separation of the preadipocyte-containing stromal cell fraction and
mature adipocytes from white adipose tissue, epididymal fat depots
were digested with collagenase (1 mg/mL, SigmaeAldrich) at 37 C in
Krebs-HEPES-Bicarbonate buffer and centrifuged, as previously
described [52]. Tissues were homogenized directly into Trizol reagent
for RNA analysis or lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl,MOLECULAR METABOLISM- (2018) 1e10
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1% Triton X-100, 1 mM EDTA with protease inhibitors (Complete mini
from Roche)) for protein work. mRNA was extracted using RNeasy kits
(Qiagen), normalized for cDNA synthesis, and expression assessed by
quantitative RT-PCR using Taqman reagents on a 7900HT Real Time
PCR cycler. A list of probes used (Applied Biosystems) can be found in
Supplemental Table 1. Protein expression was analyzed by western
blotting from clariﬁed lysates normalized for protein content by BCA
method (Bio-Rad), all as previously described [49] using antibodies
against NNAT (Abcam, ab27266).
2.6. PCR analysis of placental PEG expression
Pooled cDNA from placenta of at least four wild type (129S2/Sv)
conceptuses at various time points, and also from whole brain at P0
were ampliﬁed by standard PCR using primers for Nnat and other
paternally expressed genes listed in Supplemental Table 2.
2.7. Statistical analyses
Data sets were analyzed for normal distribution using the D’Agostino-
Pearson normality test. Statistical signiﬁcance between groups was
determined using GraphPad Prism 7 by 2-tailed Student’s t test,
ManneWhitney U test or ANOVA. The ManneWhitney U test, or
KruskaleWallis test were used as a nonparametric equivalent. Bon-
ferroni (or Dunn’s for nonparametric) and Geisser-Greenhouse post hoc
tests to correct for multiple comparisons and repeated measures were
performed where required. Signiﬁcance of the difference in observed
vs expected appearance of a particular genotype was determined
using the chi-squared test. A probability of error less than 5% was
considered signiﬁcant (i.e., p < 0.05) and general statistical infor-
mation for individual experiments (p values and n numbers) can be
found in the ﬁgure legends.Figure 1: Juvenile Nnat deﬁcient mice on a 129S2/Sv background display a ‘catch up’ gro
(paternal deletion) mice from weaning age (3 weeks) (n ¼ 19 and 17 for wild type an
mean  SEM. (C) Wet weights of wild type and Nnatþ/p embryos at E14.5 and E18.5 time
as mean  SD. (D) Representative H&E-stained sections through placenta taken from w
bar ¼ 500 mm. Dec ¼ maternal decidua, Jz ¼ junctional zone, Lz ¼ labyrinth. (E) PCR ana
least four wild type 129S2/Sv placentas between embryonic stages E9.5e14.5. Ampliﬁcati
Body weights of wild type and Nnatþ/p male mice from 10 days old (P10) until weaning
represented as mean  SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
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3.1. Nnat deﬁcient juveniles on a 129S2/Sv background have
reduced growth rates in the nest
Recently, global deletion of Nnat was shown to cause hypervariable
adiposity in adult mice on C57BL/6J background, with a ‘bimodal’
distribution of body weights and two subpopulations of normal and
obese mutant animals [42]. Our adult (12 week old) cohorts of Nnatþ/p
mice on C57BL/6J background showed a similar bimodal body weight
distribution but with a subpopulation of lean, rather than obese, Nnat
null animals, which was not evident upon maternal deletion
(Supplemental Figure 1A-C). Relative leanness in this subpopulation of
paternally-deleted mice on C57BL/6J background was at least partly
due to a reduction in adiposity with no differences (or evidence of
bimodality) in terms of food intake or sensitivity to exogenous leptin
(Supplemental Figure 1D, [41]). Despite this bimodal distribution in
Nnatþ/p mice on C57BL/6J background, this did not signiﬁcantly in-
ﬂuence body weight up until 20 weeks of age, either on standard chow
or after 20 weeks on a high fat diet (HFD) (Supplemental Figure 1E, [41]).
This lack of striking body weight phenotype led us to assess these
parameters in Nnatþ/p mice on 129S2/Sv background. However, a
bimodal body weight distribution was not present in 12 week old Nnatþ/
p mice on 129S2/Sv background (Supplemental Figure 1F, G).
In view of the key roles of imprinted genes in placental, fetal, and
early postnatal growth and their inﬂuence on metabolic phenotypes in
adulthood via such roles, we next undertook a series of studies to
understand the role of neuronatin in these processes. At weaning (3
weeks old, P20), both male and female paternally-deleted Nnat
(Nnatþ/p) mice on a 129S2/Sv background had signiﬁcantly lower
body weights (Figure 1A,B) but by early adulthood (10 weeks old,wth phenotype. (A, B) Body weights of male (A) and female (B) wild type and Nnatþ/p
d Nnatþ/p mice respectively, n ¼ 17 and 18 for females). Data is represented as
points (n ¼ 22 and 26 for E14.5 and E18.5 respectively per genotype). Data represented
ild type and Nnatþ/p embryos at E14.5 and E18.5 (n ¼ 5 mice per genotype). Scale
lysis of Nnat (Peg5), Peg3, Peg6 and Peg10 expression in pooled cDNA extracted from at
on in pooled cDNA from four 129S2/Sv P0 whole brains served as a positive control. (F)
age (P20) (n ¼ 17 and 20 mice for wild type and Nnatþ/p mice respectively). Data
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mice showing no difference in body weight compared to wild type
controls (Supplemental Figure 1H, I). This growth restriction in ju-
venile mice and subsequent post-natal catch up growth on a 129S2/
Sv background was absent in mice on a C57BL/6J background [41].
To assess whether reduced growth in utero contributed to the
observed early postnatal growth restriction, we measured fetal
weights and assessed placental structure at embryonic day (E) 14.5
and E18.5. There was no evidence for the loss of Nnat deﬁcient mice
in utero (wild type pups at P14, observed 75, expected 71.5; Nnatþ/
p observed 68, expected 71.5; c2 ¼ 0.3427, mean litter
size ¼ 6.8  0.8, n ¼ 21 litters). There was also no evidence of fetal
growth restriction at either embryonic stage, and placental weight
was normal at both time points, with no overt effect on placental
structure apparent from H&E stained midline sections (Figure 1C,D
and Supplemental Figure 1J). Placental glycogen, which is proposed
to provide a source of energy for fetal growth during late gestation
[53], was also unaltered at both time points (Supplemental
Figure 1K). The absence of a placental phenotype in Nnatþ/p con-
ceptuses is consistent with the observation that unlike the paternally
expressed genes Peg3, Peg6, and Peg10, Nnat expression was not
detectable in the mouse placenta between E9.5 and E14.5
(Figure 1E). In the absence of any signs of fetal growth restriction, we
next recorded body weights of Nnat deﬁcient pups between P10,
when pups were genotyped, and weaning age (P20). We observed a
clear reduction in body mass that was statistically signiﬁcant at P15,
and more pronounced at P20 (Figure 1F), suggesting a progressive
failure to gain weight. Overall it appears that deletion of Nnat on a
129S2/Sv background causes an early postnatal growth restriction in
mice that is independent of fetal growth abnormalities.
3.2. Restricted growth in Nnat deﬁcient juveniles is associated with
reduced adipose accumulation
In the ﬁrst few days of postnatal life, mice receive mainly fat-based
nutrition through milk feeding, to support early growth and meta-
bolism. Between P10 and P21, during which point mice begin to leave
the nest, juveniles start to accumulate adipose depots, and therefore
require a switch to a lipogenic state in which carbohydrate becomes
the major source of fuel [11,54]. Nnat is highly expressed in adipose
tissue and has been previously reported to potentiate adipogenesis
[29]. At P20, even when normalized to body weight, Nnatþ/p mice
had reduced fat pad mass in two distinct white adipose tissue (WAT)
depots (epididymal and femoral subcutaneous) and reduced inter-
scapular brown adipose tissue (BAT) mass, indicating disproportionateFigure 2: Growth restricted Nnat deﬁcient juveniles accumulate less adipose tissue
ED ¼ epididymal, SC ¼ subcutaneous (n ¼ 5 mice per genotype). (B) Representative H&E-
weaning age (P20). Scale bar ¼ 50 mm. (C) Quantiﬁcation of images shown in B represente
genotype). In all panels, data represented as mean  SEM (*p < 0.05).
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major organs including the liver, kidney, and brain were signiﬁcantly
lighter in Nnatþ/p mice, they remained in proportion to overall body
weight (Figure 2A). Reduced WAT mass appeared to be due to smaller
adipocytes, suggesting a defect in early lipid storage and WAT accu-
mulation (Figure 2B,C). Previous work has reported that RNAi knock-
down of Nnat expression in primary mouse adipocytes promotes a
thermogenic ‘browning’ response, with increased expression of Ucp1
and oxidative phosphorylation genes Pgc1a, Cox8b, and Cox4 [55]. We
found that neuronatin is expressed in mature white adipocytes but not
BAT, and that core body temperature in P20 Nnatþ/p mice was un-
altered, suggesting that reduced body fat in these animals was not
caused by an increase in thermogenesis (Supplemental Figure 2A, B).
In agreement with this, we found no differences in expression of
adipocyte thermogenic markers Ucp1, Pgc1a, Prdm16, and Dio2 in
either BAT or subcutaneous WAT of Nnatþ/p mice (Supplemental
Figure 2C, D). Overall, relative leanness in Nnat deﬁcient juveniles
appears to result from reduced adipose tissue accumulation during this
early stage.
3.3. Adult Nnat deﬁcient mice have reduced energy expenditure
and display leptin resistance and hyperphagia
Nnat is expressed in key hypothalamic neurons governing energy
homeostasis, where it is regulated by nutrient supply and also leptin
[28,39e41]. Adult male Nnatþ/p mice (P70) on a 129S2/Sv back-
ground (at which point they had reached the same body weight as
their wild type littermates (Supplemental Figure 1H)) had reduced
energy expenditure as measured by indirect calorimetry (Figure 3A).
This difference was most pronounced during the more active night
cycle (Figure 3A). Nnatþ/p mice also had lower levels of physical
activity, as measured by horizontal beam breaks over the same time
period, which was again more prominent during the night cycle, and
also in the novel environment (Figure 3B). Despite no difference in ad
libitum food intake over a 3-day period, feeding during the 8-hour
period immediately following an overnight fast was increased in
mutant mice (Figure 3C, Supplemental Figure 3A). Furthermore,
whereas peripheral leptin administration in wild type mice resulted in
substantially decreased food intake over a 3-day period, this effect
was severely blunted in Nnatþ/p mice (Figure 3D). This reduction in
leptin sensitivity occurred despite unaltered levels of endogenous
leptin in the serum of mutant mice at P70 (Supplemental Figure 3B).
Together this indicates that adult Nnat deﬁcient mice have lower
energy expenditure, reduced sensitivity to the anorexigenic effects of
leptin, and are hyperphagic.. (A) Organ to body weight ratios of wild type and Nnatþ/p mice at weaning age (P20)
stained sections through subcutaneous WAT taken from wild type and Nnatþ/p mice at
d as percentage adipocyte size compared with control (wild type) mice (n ¼ 5 mice per
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Figure 3: Adult Nnat null mice on a 129S2/Sv background display hyperphagia and reduced energy expenditure. (A) Energy expenditure calculated by indirect calorimetry
using CLAMS over a period of 96 h in young adult (P70) wild type and Nnatþ/p male mice (n ¼ 8 mice per genotype). Black bars indicate periods of dark cycles. (B) Physical
activity in the same mice as A expressed as horizontal beam breaks over time. (C) Food intake following an overnight fast in wild type and Nnatþ/p male mice (n ¼ 10 animals per
genotype). (D) Food intake alterations (percentage change) in response to exogenous leptin compared to saline crossover control in wild type and Nnatþ/p male mice (n ¼ 12
animals per genotype). In all panels, data represented as mean  SEM (*p < 0.05, **p < 0.01).3.4. Deletion of Nnat worsens age- and diet induced-obesity
Restricted postnatal growth and development have been shown to
inﬂuence health status in adult life with an increased risk of metabolic
diseases such as obesity and diabetes [26,27]. Additionally, single
nucleotide polymorphisms in the human NNAT locus are associated
with extreme childhood obesity, and reduced NNAT expression has
been reported in the adipose tissue of obese children [28,42]. Both an
early growth restriction (Figures 1 and 2) and perturbed hypothalamic
leptin sensing (Figure 3) suggest that adult Nnatþ/p mice may be
susceptible to obesity in later life. When Nnat deﬁcient mice of both
sexes were aged to over a year old (P400) on a standard chow diet,
Nnatþ/p mice demonstrated increased adiposity, which was statis-
tically signiﬁcant in aged females (Figure 4A,B). When challenged with
a HFD, male Nnatþ/p mice gained more weight than wild type lit-
termates over the feeding period (Figure 4C). HFD-feeding of female
Nnatþ/p mice displayed the same pattern, although did not reach
statistical signiﬁcance (p ¼ 0.11, Figure 4D). Nnatþ/p mice of both
sexes also accumulated more body fat as a ratio of body weight than
HFD-fed wild type controls (Figure 4E,F).
3.5. Nnat deﬁcient mice have reduced pituitary GH content and
secretion
Our recent ﬁndings have indicated that NNAT interacts with the SPC in
pancreatic beta cells, and that this is critical for maintaining adequate
storage and secretion of mature insulin [41]. Circulating insulin is
required for accumulation of adipose tissue [56,57], and defects in the
postprandial elevation of insulin may contribute to the growth defects
and reduced adipocyte mass seen early in the early postnatal period inMOLECULAR METABOLISM- (2018) 1e10  2018 The Authors. Published by Elsevier GmbH. This is an
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other hormones may contribute to these abnormalities. Therefore, we
assessed the content and secretion in Nnatþ/p mice of GH, as this is
another key circulating hormone crucial for growth and adipose accu-
mulation in the postnatal period [58,59] and neuronatin is expressed at
high levels in the anterior pituitary [34]. GH content was appreciably
reduced in the pituitary of null mutant mice compared to wild type lit-
termates (Figure 5A). This was in the absence of any reduction to
expression of GH mRNA, or changes in the mRNA expression of other
key markers in the pituitary including Pit1, Pomc, Tshb, Tpit, and Crhr
(Figure 5B). Alongside this reduced GH content, and similar to our
ﬁndings for blunted glucose-evoked insulin secretion in Nnatþ/p mice,
pituitary GH secretion into the blood under hypoglycemia-stimulated
conditions was severely reduced in these null animals (Figure 5C).
4. DISCUSSION
Imprinted genes regulate growth and development in early life, both in
utero and in the postnatal period. Altered imprinted gene expression in
both human disease states and in mouse genetic models demon-
strates the importance of their dosage and function, with an array of
metabolic disorders stemming from inappropriate expression levels of
imprinted genes [17e20,22e25]. Moreover, abnormal growth in the
postnatal period, due to genetic or environmental causes (such as
reduced or excessive nutrient availability) is itself strongly associated
with the risk of developing metabolic disease in later-life [26,27].
Previous data has suggested that the imprinted gene Nnat, is asso-
ciated with human obesity [28,42]. It has also been suggested thatopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 5
Figure 4: Nnat deﬁcient mice on a 129S2/Sv background are more prone to obesity upon aging or HFD-feeding. (A, B) Adiposity in male (A) and female (B) wild type and
Nnatþ/p mice was quantiﬁed by MRI scanning in chow-fed, 400 day old mice (P400) (n ¼ 11 and 9 for wild type and Nnatþ/p male mice respectively, n ¼ 9 and 8 for females).
(C, D) Body weights of male (C) and female (D) wild type and Nnatþ/p mice fed high fat diet (HFD) for 30 consecutive weeks (n ¼ 15 and 13 mice per genotype respectively for
males, n ¼ 12 mice for females). (E, F) Adiposity in male (E) and female (F) wild type and Nnatþ/p mice was quantiﬁed by MRI scanning in mice fed high fat diet for 30 weeks
(HFD) (n ¼ 15 and 13 mice per genotype respectively for males, n ¼ 12 mice for females). In all panels, data represented as mean  SEM (*p < 0.05).
Figure 5: Nnat deﬁcient mice on a 129S2/Sv background have defective pituitary gland growth hormone content and secretion. (A) Growth hormone (GH) content was
quantiﬁed in whole pituitary gland from wild type and Nnatþ/p mice and normalized to total protein (n ¼ 6 for wild type, n ¼ 5 for Nnatþ/p). (B) Quantitative RT-PCR analysis of
mRNAs encoding key genes in the pituitary gland of wild type and Nnatþ/p mice. Hprt mRNA expression was used as an internal control and data is represented relative to wild
type mice (n ¼ 6 animals per genotype). (C) Measurement of GH secretion in vivo under basal and stimulated (hypoglycemic) conditions in wild type and Nnatþ/p male mice
(n ¼ 14 animals per genotype). In all panels, data expressed as mean  SEM (*p < 0.05, ***p < 0.001).
Original ArticleNnat forms part of a TRIM28-dependent imprinted gene expression
network and that this is involved in the stochastic obesity seen in in-
bred mouse strains. Nnat null mice have thus been reported to display
a bimodal body weight phenotype with normal and obese sub-
populations [42]. We also detected, in our own targeted allele of
neuronatin, a bimodal body weight phenotype on a C57BL/6J back-
ground, albeit with a lean rather than obese subpopulation of mutant
mice. Therefore, this genetic manipulation did not result in any sig-
niﬁcant obesity phenotype on this background, and we found no6
 2018 The Authors. Published by Elsevier Gevidence for any underlying changes to energy homeostasis such as
feeding and leptin sensitivity. Moreover, when examined on a 129S2/
Sv background, we found little evidence for bimodal body weight
distribution in Nnat null mice. Therefore, while both studies hint that
loss of neuronatin is associated with some phenotypic variation with
respect to body weight on a C57BL/6J background this does not seem
to be a robust observation. The reasons underlying the discrepancies
between our ﬁndings and those of Dalgaard et al. [42] remain to be
elucidated. They could reﬂect subtle variations in the studyMOLECULAR METABOLISM- (2018) 1e10
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environment (such as housing conditions, diet and microbiota effects)
or differences in the targeting approaches and genetic background in
the two distinct Nnat null mouse models used.
The surprising lack of body weight phenotype at either postnatal or
adult stages on a C57BL/6J background prompted us to study these
parameters in mice on the 129S2/Sv background. This strain has
previously revealed early growth defects in mutant mice that were not
apparent on the C57BL/6J background [44e48]. Deletion of Nnat on
the 129S2/Sv background resulted in growth restriction in the early
postnatal period with subsequent catch up growth after weaning, a
defect that was absent on C57BL/6J background [41]. Following this
catch up period, adult 129S2/Sv Nnat null mice had decreased energy
expenditure, blunted leptin sensitivity and hyperphagia, and were more
susceptible to both aging and HFD-induced obesity in later-life. The
present studies demonstrate the importance of the imprinted gene
neuronatin in early postnatal growth, particularly on different genetic
backgrounds. Furthermore, loss of neuronatin subsequently affects
feeding behavior and energy expenditure, and therefore susceptibility
to obesity, in adulthood.
Imprinted genes are expressed in key tissues governing resource
allocation such as the placenta, WAT, and hypothalamus. Growth rates
both before birth and in the immediate postnatal period can have a
strong causal effect on metabolic phenotypes, with intrauterine and
postnatal growth restriction increasing the likelihood of developing
obesity in later life [26,60]. This occurs when a developing organism
responds to substandard environmental conditions during early stage
programming. Ultimately, this leads to an increased risk of developing
the metabolic syndrome in later life, a phenomenon known as meta-
bolic programming [61,62]. Proposed mechanisms for how this early-
life adversity can be detrimental to long-term metabolic health include
permanent changes in organ structure and programmed epigenetic
changes in gene expression [63,64]. Indeed, there is evidence that
individual imprinted (Peg3, Pref1/Dlk1, Gnasxl, Cdkn1c, and Grb10)
and also non-imprinted (Gck) genes can regulate both prenatal growth
and postnatal energy regulation [8,65e68]. We did not detect Nnat
expression in the placenta at various embryonic stages, in agreement
with previous ﬁndings [69]. We also found no evidence for fetal growth
restriction or placental defects in Nnat null embryos indicating that, at
birth, these mutant mice are phenotypically indistinguishable from
their wild type littermates suggesting that neuronatin does not play a
major role in fetal growth.
Generally, paternally expressed genes enhance fetal and/or postnatal
growth. Although fetal growth was normal in Nnat null embryos, we
found that these animals developed a postnatal restriction in growth
while still in the nest, which worsened from P10 until weaning age
(P20). Postnatal mammals must adapt to independent life during this
period, maintaining their core body temperature, beginning to acquire
food other than that provided by their mother, and regulating their own
metabolism. Although core body temperature was unaltered in Nnat
null mice, growth restricted mutant mice had disproportionate re-
ductions in adipose tissues when measured as percentage of body
weight, in contrast to proportionate reductions in weights for other
major organs. We show that NNAT is expressed in mature white ad-
ipocytes, and indeed previous in vitro studies have demonstrated that
Nnat is able to potentiate adipogenesis [29]. After weaning, this body
weight difference diminishes between Nnat deﬁcient juveniles and
their wild type littermates. This so-called ‘catch up’ growth acts to
restore the size of the organism back to their ‘normal’ growth trajectory
(reviewed in [26]) and is a common observation upon genetic modi-
ﬁcation of imprinted gene dosage in young mutant mice, often most
prominent between P7 and P21 (reviewed in [70]). These mouseMOLECULAR METABOLISM- (2018) 1e10  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.commodels with altered expression of imprinted genes demonstrating a
failure to thrive in the early postnatal period mimics the pattern
observed in human imprinting disorders such as PradereWilli and
SilvereRussell syndrome [19,20].
Modiﬁcation of imprinted gene dosage for various paternally expressed
genes is also a risk factor for obesity in later life. Adult mice deﬁcient in
Necdin (Ndn) or mice with overexpression of Mest (Peg1) are obese
owing to increases in adipose expansion [71,72]. Obesity also results
from deletion of paternally expressed genes, Peg3, Pref1/Dlk1, or
Magel2 with observed differences in hyperphagia and energy expen-
diture, all of which demonstrate catch up growth in null mice
[66,67,73]. In our young adult Nnat null mice, we ﬁnd a combination of
reduced energy expenditure, reduced physical activity, hyperphagia,
and partial leptin resistance, at which point null mice had reached the
same body weight as their wild type littermates. These metabolic al-
terations were consistent with subsequently worsened obesity in aged,
or HFD-fed, Nnat mutant mice. The fact that body weight and adiposity
are unaltered in adult (P70) Nnat null mice suggests that the defective
leptin sensitivity observed in these mice is a primary defect, rather than
being secondary to the development of obesity. Indeed, Nnat is
expressed in leptin receptor-expressing neurons in the hypothalamus
that dictate feeding behaviour and energy expenditure and is also
upregulated upon leptin administration in mice [28,74].
We have recently shown that Nnat is able to potentiate signal peptidase
processing of preproinsulin and that loss of Nnat expression in
pancreatic beta cells results in defective insulin storage and therefore
glucose-evoked insulin secretion, which is particularly prominent un-
der conditions of nutrient excess [41]. It is therefore possible that the
intensive period of growth and development during the postnatal phase
(when expression of Nnat peaks) requires Nnat-mediated increases in
insulin secretion to maintain this growth demand, and adequate adi-
pose accumulation. Clearly, circulating insulin is required for accu-
mulation of adipose [56,57] and indeed, postnatal exogenous insulin
administration in rodents results in greater body weight gain [75,76].
Furthermore, evidence that insulin action plays a much greater role in
postnatal rather than prenatal growth is demonstrated by the fact that
mice with either Ins1 or Ins2 heterozygosity are born with only a slight
growth defect and are metabolically healthy. This is in contrast to the
deterioration of glucose homeostasis that occurs in the postnatal
period in these animals [77]. Insulin secretion in our postnatal or adult
Nnat null mice was not reduced to the point where we detected any
changes in glucose homeostasis although this may be background-
dependent, as mice with insulin signalling defects on a 129S2/Sv
background display minimal defects in glucose homeostasis [78].
However, it is clear that neuronatin is critical for precise matching of
insulin production and secretion to nutrient availability to permit normal
responses to increased energy intake. Therefore, loss of neuronatin
may perturb appropriate deposition of lipids due to dysregulated post-
prandial insulin secretion. In addition to our documented role in insulin
secretion via effects on early peptide handling [41], we further
demonstrate in this work that neuronatin is also required for adequate
storage and secretion of pituitary GH in vivo. GH is another anabolic
hormone with a key role in postnatal growth and adipose accumulation
[58,59]. It therefore appears that in the immediate postnatal phase, in
which growth rates are particularly high, that Nnat is required to match
the demand for increased production of circulating hormones such as
insulin and GH.
Neuronatin is expressed in the hypothalamus and adipose tissue and
our current studies do not rule out a role for neuronatin action directly
in these key regulatory tissues in the growth and metabolic defects we
observe. However, to fully elucidate the tissue-speciﬁc roles ofopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 7
Original Articleneuronatin in adipose tissues and various hypothalamic nuclei will
require extensive further work with mice with loss of function in
speciﬁc cell populations.
In summary, this work demonstrates that neuronatin deletion in mice
on a 129S2/Sv background causes a transient postnatal growth re-
striction with subsequent catch up growth following weaning. In
adulthood these animals display numerous obesogenic phenotypes
that culminate in increased susceptibility to obesity from either aging
or high fat feeding. Collectively, these data demonstrate the impor-
tance of the imprinted gene neuronatin in postnatal growth, adult
energy homeostasis, and the pathogenesis of obesity.
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